{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"}],"units":"Participants"}],"description":"The primary endpoint will be the best overall response rate (ORR)","groups":[{"description":"All patients received oral panobinostat, lenalidomide and dexamethasone as per protocol","id":"OG000","title":"Panobinostat, Lenalidomide and Dexamethasone"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Only Len Refractory Patients","reportingStatus":"POSTED","timeFrame":"up to 4 years","title":"Overall Response Rate for Len Refractory Patients","type":"PRIMARY","unitOfMeasure":"Participants"}